HBOT Conversations:

Dr. Hemal Mehta & Vibrant Health University

Dr. Hemal Mehta, MD is a Medical Director and an Independent Medical Examiner who focuses on pain management through a Regenerative medicine approach. Dr. Mehta is Board Certified in Physical Medicine and Pain Management. He received his Doctor of Medicine Degree from Ross University School of Medicine and completed his residency at East Carolina. He is the Medical Director of Vibrant Health of North Carolina, Tennessee Integrative Pain Institute, and TN Integrative Healthcare:  Musculoskeletal and Regenerative Center; additionally, Dr. Mehta is the attending physician at Nashville Regenerative Orthopedics. Dr. Mehta is the 2013 recipient of the Inaugural Patient Appreciation Award at Nashville Academy of Medicine, and the 2004 Research Resident of the Year for East Carolina University. Dr. Mehta has extensive experience with stem cell proliferation, and angiogenesis.  He has incorporated Ozone Injection Therapy, PRP (Platelet-Rich Plasma) Injections, Hyperbaric Oxygen Therapy and Regenerative Matrix and Regenerative Medicine Procedures – to name a few – into his integrative wellness & longevity medical practices.

Subscribe. Join the discussion. Share the hope.

Watch the Podcast

HBOT News Network welcomes back Dr. Hemal V. Mehta, M.D.; Medical Director of Vibrant Health of North Carolina. Dr. Mehta has joined HBOT News Network three times previously, where we focused heavily on the topics of fasting & regenerative medicine – see Dr. Mehta & Fasting, Dr. Mehta & Fasting (Part 2), and Dr. Mehta & Regenerative Medicine.

We are thrilled to have Dr. Mehta return to discuss Vibrant Health University. Vibrant Health University is a new start-up educational program through Vibrant Health. It is a way to help educate, not just the public, but also providers who are interested in performing regenerative therapies, regenerative injections, and providing an alternative to patients that’s not typically available.

Vibrant Health University wants to steer the medical field and general public away from the traditional heavy focus of pharmacology and surgical techniques; and educate people more on the integrative approaches available for regenerative therapies and regenerative treatments. What people can expect from Vibrant Health University (once it gets up and going), is a variety of online programs and podcasts they can watch.  Then, if interested further, physicians can choose the option for an in-person educational program where Dr. Mehta or his team can visit the physician’s office (or the physician can visit them) and the physician can then witness live demonstrations, and learn how to do proper procedures for regenerative treatments, while incorporating their protocols into their treatment plans.

The courses at Vibrant Health University will be a structured program with a certification process.  Dr. Mehta explains that they are planning to provide different tiers. For example, a lower tier, a medium tier, and a higher tier of education to providers based on their level of expertise, and based on how much knowledge they already have and how much they want to obtain. The ultimate goal of the program is to have the courses accredited by the appropriate certifying boards to count as continuing medical education for physicians.

Dr. Mehta & di Giralomo spend time discussing the importance of physician education, the continued benefits of fasting, and how to gain control of excessive inflammation.

Dr. Mehta remind us of Vibrant Health’s focus — to integrate traditional and non-traditional medicine to give each patient the best outlook and care. Ultimately, integrative medicine is integrating functional medicine and holistic therapies with what we’ve learned through history regarding how the human body works.  God gave us everything we need to survive from the beginning of human life. Dr. Mehta ends this segment by explaining through the study of medicine, it’s incredibly difficult to not believe that there is a God or a higher power that has created this body.  The human body is made to be able to tolerate all kinds of different injuries, in all kinds of different aspects of life, while adapting to the environment. There is absolutely no other machine that man has ever made that’s even similar to the divine healing capabilities of the human body.

If you’d like to know more about Vibrant Health University, please contact Vibrant Health at www.vibranthcs.com/contact/

Guest

Robert Beckman

Dr. Hemal Mehta

Dr. Hemal Mehta specializes in non-opioid treatment for joint pain, osteoarthritis, spine pain and neuropathy. He is a board-certified Physical Medicine and Rehabilitation physician whose goal for patients is to reduce pain while increasing their level of function & quality of life. He received his Doctor of Medicine Degree from Ross University School of Medicine and completed his residency at East Carolina. Dr. Mehta is the Medical Director of Vibrant Health of North Carolina, Tennessee Integrative Pain Institute, and TN Integrative Healthcare:  Musculoskeletal and Regenerative Center; additionally, Dr. Mehta is the attending physician at Nashville Regenerative Orthopedics. He is the 2013 recipient of the Inaugural Patient Appreciation Award at Nashville Academy of Medicine, and the 2004 Research Resident of the Year for East Carolina University. He is a member of the American Academy of Physical Medicine & Rehabilitation, American Society of Interventional Pain Physicians, and American Association of Neuromuscular and Electrodiagnostic Medicine.

Dr. Mehta has extensive experience with stem cell proliferation and angiogenesis. For years he has incorporated Hyperbaric Oxygen Therapy into his integrative approach for pain management and rehabilitation, and he has also preformed the following procedures fluoroscopically: Translaminar Cervical and Lumbar ESI, Transforaminal Lumbar ESI, Lumbar Selective Nerve Root Blocks, Stellate Ganglion Blocks, Lumbar Sympathetic Blocks, SIJ injections, Hip Joint Injections, Piriformis Injections, Cervical and Lumbar Facet Joint Injections, Medial Branch Nerve Blocks, Radiofrequency Ablation of Medial Branch Nerve, Discography, Percutaneous Disc Decompression/ Intradiscal Injections, Spinal Cord Stimulator Lead Trial, PRP/ Regenerative Matrix/ Regenerative Medicine Procedures for Spine, Peripheral Joints, and Nerves, P-Shot/O-shot, Juvederm Anti-aging, and Ozone Injection Therapy.

Subscribe Now, It’s Free!

[contact-form-7 id="65934" title="Subscribe"]

Recent HBOT News

Clinical Trial – Efficacy Study of Riociguat and Its Effects on Exercise Performance and Pulmonary Artery Pressure at High Altitude

During ascent to high altitude there is a physiologic response to hypoxia that results in an
elevated pulmonary arterial pressure associated with decreased exercise performance,
altitude-induced pulmonary hypertension, and high altitude pulmonary edema (HAPE). Riociguat
is a novel agent from Bayer Pharmaceuticals that has already demonstrated effectiveness in
the treatment of pulmonary hypertension, and it may prove to be beneficial in cases of
altitude-induced pulmonary hypertension or HAPE. This research study, composed of 20 healthy
volunteers ages 18-40 years, will attempt to mimic the decreased oxygen supply and elevated
pulmonary artery pressures found in conditions of high altitude, allowing observation of the
effects of riociguat and exercise on pulmonary arterial pressure, arterial oxygenation, and
exercise performance. Prior to entering the hypobaric chamber, subjects will have radial
arterial lines and pulmonary artery catheters placed to obtain arterial and pulmonary artery
pressure measurements. Subjects will then enter the hypobaric chamber and perform exercise
tolerance tests at a simulated altitude of 15,000 feet on an electrically braked ergometer
(exercise bike) before and after administration of riociguat. If, after administration of
riociguat and exposure to a simulated altitude of 15,000 feet, the exercise performance is
improved and observed pulmonary artery pressures are lower than those measurements seen prior
to administration of riociguat, this could lead to development of a prophylactic and/or
treatment strategy for HAPE and high-altitude pulmonary hypertension. Statistical analysis
will compare the variables of pulmonary artery pressure, radial arterial pressure,
ventilation rate, cardiac output, PaO2, and work rate at exhaustion before and after
administration of the drug riociguat. The investigator’s hypothesis is that riociguat will
decrease pulmonary artery pressure and improve gas exchange and exercise performance at
altitude.